Company Search:
Advanced Search
Sponsored Links
Bioton SA Company Snapshot
Bioton SA operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Bioton SA with three other pharmaceutical manufacturers in Europe: Olainfarm AS of Latvia (2015 sales of 97.39 million Euro [US$105.17 million] ), Dottikon ES Holding AG of Switzerland (96.49 million Swiss Francs [US$97.37 million] of which 82% was Pharma Products), and Cathay International Holdings Ltd which is based in the United Kingdom (£79.27 million [US$98.84 million] of which 77% was Lansen Group).

Sales Analysis. During the year ended December of 2015, sales at Bioton SA were 404.41 million Polish New Zlotys (US$102.46 million). This is an increase of 7.2% versus 2014, when the company's sales were 377.30 million Polish New Zlotys. The sales level in 2015 was fairly close to the level five years ago: in 2010, Bioton SA had sales of 378.60 million Polish New Zlotys. Sales of Fisiopharma saw an increase that was more than double the company's growth rate: sales were up 217.5% in 2015, from 22.63 million Polish New Zlotys to 71.85 million Polish New Zlotys. Bioton SA also saw significant increases in sales in Scigen Group (up 18.2% to 86.63 million Polish New Zlotys) . Not all segments of Bioton SA experienced an increase in sales in 2015: sales of Biolek fell 92.7% to 40,000.00 Polish New Zlotys. (However, this segment's sales were only a very small portion of the company's overall sales). Bioton SA also experienced decreases in sales in Mj Biopharm (down 8.4% to 62.30 million Polish New Zlotys) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Bioton SA
  Stock Performance Chart for Bioton SA
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): 7.20
(Figures in Polish New Zlotys)
1 Week -0.3%   13 Weeks -4.4%  
4 Weeks -12.5%   52 Weeks -38.6%  
Bioton SA Key Data:
  Ticker: BIO Country: Poland
  Exchanges: WAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 404,408,000
(Year Ending Jan 2016).
Employees: 963
  Currency: Polish New Zlotys Market Cap: 618,222,240
  Fiscal Yr Ends: December Shares Outstanding: 85,864,200
  Share Type: Akcje Closely Held Shares: 70,935,690
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.